Chimeric Antigen Receptor- T Cell Therapy - In Vitro Activation and Comprehensive Expansion of Specialized T-Cells to Neutralize Deadly Cancerous Cells

Utkalendu Suvendusekhar Samantaray and Rutupurna Satapathy
Additional contact information
Utkalendu Suvendusekhar Samantaray: Bhubaneswar, Odisha, India
Rutupurna Satapathy: School of Biotechnology, KIIT University, India

Biomedical Journal of Scientific & Technical Research, 2022, vol. 45, issue 4, 36748-36752

Abstract: Chimeric antigen receptor based therapy is the most promising and new treatment for cancer...

Keywords: Immunological Disease; Nuereological Disorders; Journals on Nuero Imaging; Journals on Regenarative Diseases; Journals on Vaccination; Biomedical Open Access Journals; Biomedical Journal Impact Factor; Biomedical Journal Articles; Biomedical Journal Impact Factor; Open Access Journals on Surgery; Journals on Medical Drug and Theraputics (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.007246.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.007246.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:45:y:2022:i:4:p:36748-36752

DOI: 10.26717/BJSTR.2022.45.007246

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().